Cargando…

AN ANTIVIRAL SUBSTANCE FROM PENICILLIUM FUNICULOSUM : VI. PREVENTION OF THE ESTABLISHMENT OF PASSIVE IMMUNITY TO SEMLIKI FOREST VIRUS INFECTION IN MICE BY HELENINE

1. Helenine prevents the establishment in mice of passive viral immunity by anti-Semliki serum of swine, rabbit, or guinea pig origin. 2. A period of 12 days must elapse, between the antiviral serum administration and challenge with virus, for prevention of the establishment of passive immunity to b...

Descripción completa

Detalles Bibliográficos
Autor principal: Shope, Richard E.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1966
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2138221/
https://www.ncbi.nlm.nih.gov/pubmed/5944346
_version_ 1782143512798560256
author Shope, Richard E.
author_facet Shope, Richard E.
author_sort Shope, Richard E.
collection PubMed
description 1. Helenine prevents the establishment in mice of passive viral immunity by anti-Semliki serum of swine, rabbit, or guinea pig origin. 2. A period of 12 days must elapse, between the antiviral serum administration and challenge with virus, for prevention of the establishment of passive immunity to become apparent. This period is believed to correspond to that in which injected antibody persists in circulation in the injected host. 3. Helenine is effective in preventing the establishment of passive viral immunity by heterologous antiviral sera when it is administered any time during a period of 6 days, extending from 4 days before to 2 days after injection of the antiviral serum. 4. Helenine does not prevent the establishment of passive viral immunity by antiviral sera of mouse origin (homologous). 5. Evidence is presented to indicate that the phenomenon of the prevention of the establishment of passive viral immunity by heterologous antiviral sera is not effected directly, but rather is mediated through some substance that helenine induces the injected host to elaborate. 6. The capacity to prevent the establishment of passive viral immunity could not be exhausted by repeated preceding injections of helenine at 2- or 3-day intervals. 7. Evidence is presented to indicate that the helenine-induced material does not act upon antiviral antibody per se but rather on heterologous foreign protein that happens to be labeled as Semliki Forest virus antibody. This helenine-induced material, whatever its nature, appears to enhance the capacity of the injected host to recognize and dispose of foreign protein. 8. Statolon, a material that like helenine is a known inducer of interferon, is, like helenine, also capable of preventing the establishment of passive viral immunity by heterologous antiviral sera. 9. Experiments designed to determine whether the induced material responsible for the antipassive immunity effect of helenine is interferon have yielded inconclusive answers thus far.
format Text
id pubmed-2138221
institution National Center for Biotechnology Information
language English
publishDate 1966
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21382212008-04-17 AN ANTIVIRAL SUBSTANCE FROM PENICILLIUM FUNICULOSUM : VI. PREVENTION OF THE ESTABLISHMENT OF PASSIVE IMMUNITY TO SEMLIKI FOREST VIRUS INFECTION IN MICE BY HELENINE Shope, Richard E. J Exp Med Article 1. Helenine prevents the establishment in mice of passive viral immunity by anti-Semliki serum of swine, rabbit, or guinea pig origin. 2. A period of 12 days must elapse, between the antiviral serum administration and challenge with virus, for prevention of the establishment of passive immunity to become apparent. This period is believed to correspond to that in which injected antibody persists in circulation in the injected host. 3. Helenine is effective in preventing the establishment of passive viral immunity by heterologous antiviral sera when it is administered any time during a period of 6 days, extending from 4 days before to 2 days after injection of the antiviral serum. 4. Helenine does not prevent the establishment of passive viral immunity by antiviral sera of mouse origin (homologous). 5. Evidence is presented to indicate that the phenomenon of the prevention of the establishment of passive viral immunity by heterologous antiviral sera is not effected directly, but rather is mediated through some substance that helenine induces the injected host to elaborate. 6. The capacity to prevent the establishment of passive viral immunity could not be exhausted by repeated preceding injections of helenine at 2- or 3-day intervals. 7. Evidence is presented to indicate that the helenine-induced material does not act upon antiviral antibody per se but rather on heterologous foreign protein that happens to be labeled as Semliki Forest virus antibody. This helenine-induced material, whatever its nature, appears to enhance the capacity of the injected host to recognize and dispose of foreign protein. 8. Statolon, a material that like helenine is a known inducer of interferon, is, like helenine, also capable of preventing the establishment of passive viral immunity by heterologous antiviral sera. 9. Experiments designed to determine whether the induced material responsible for the antipassive immunity effect of helenine is interferon have yielded inconclusive answers thus far. The Rockefeller University Press 1966-07-01 /pmc/articles/PMC2138221/ /pubmed/5944346 Text en Copyright © 1966 by The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Shope, Richard E.
AN ANTIVIRAL SUBSTANCE FROM PENICILLIUM FUNICULOSUM : VI. PREVENTION OF THE ESTABLISHMENT OF PASSIVE IMMUNITY TO SEMLIKI FOREST VIRUS INFECTION IN MICE BY HELENINE
title AN ANTIVIRAL SUBSTANCE FROM PENICILLIUM FUNICULOSUM : VI. PREVENTION OF THE ESTABLISHMENT OF PASSIVE IMMUNITY TO SEMLIKI FOREST VIRUS INFECTION IN MICE BY HELENINE
title_full AN ANTIVIRAL SUBSTANCE FROM PENICILLIUM FUNICULOSUM : VI. PREVENTION OF THE ESTABLISHMENT OF PASSIVE IMMUNITY TO SEMLIKI FOREST VIRUS INFECTION IN MICE BY HELENINE
title_fullStr AN ANTIVIRAL SUBSTANCE FROM PENICILLIUM FUNICULOSUM : VI. PREVENTION OF THE ESTABLISHMENT OF PASSIVE IMMUNITY TO SEMLIKI FOREST VIRUS INFECTION IN MICE BY HELENINE
title_full_unstemmed AN ANTIVIRAL SUBSTANCE FROM PENICILLIUM FUNICULOSUM : VI. PREVENTION OF THE ESTABLISHMENT OF PASSIVE IMMUNITY TO SEMLIKI FOREST VIRUS INFECTION IN MICE BY HELENINE
title_short AN ANTIVIRAL SUBSTANCE FROM PENICILLIUM FUNICULOSUM : VI. PREVENTION OF THE ESTABLISHMENT OF PASSIVE IMMUNITY TO SEMLIKI FOREST VIRUS INFECTION IN MICE BY HELENINE
title_sort antiviral substance from penicillium funiculosum : vi. prevention of the establishment of passive immunity to semliki forest virus infection in mice by helenine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2138221/
https://www.ncbi.nlm.nih.gov/pubmed/5944346
work_keys_str_mv AT shopericharde anantiviralsubstancefrompenicilliumfuniculosumvipreventionoftheestablishmentofpassiveimmunitytosemlikiforestvirusinfectioninmicebyhelenine
AT shopericharde antiviralsubstancefrompenicilliumfuniculosumvipreventionoftheestablishmentofpassiveimmunitytosemlikiforestvirusinfectioninmicebyhelenine